Neurokine Pharmaceuticals Inc Share Price Other OTC
Equities
CAC611561100
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
03/05 | BetterLife Pharma Inc. announced that it expects to receive CAD 0.5 million in funding | CI |
01/05 | BetterLife Pharma Advances IND-enabling Studies For BETR-001 | MT |
Sales 2022 | - | Sales 2023 | - | Capitalization | 13.32M 1.11B |
---|---|---|---|---|---|
Net income 2022 | -12M -1B | Net income 2023 | -9M -751M | EV / Sales 2022 | - |
Net Debt 2022 | 139K 11.6M | Net Debt 2023 | 71.69K 5.99M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.26
x | P/E ratio 2023 |
-1.36
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.36% |
Managers | Title | Age | Since |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17/07/17 |
Moira Ong
DFI | Director of Finance/CFO | 49 | 26/10/26 |
Chief Operating Officer | 67 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17/07/17 |
Robert Metcalfe
BRD | Director/Board Member | 84 | 21/20/21 |
Wolfgang Renz
BRD | Director/Board Member | 54 | 05/15/05 |
1st Jan change | Capi. | |
---|---|---|
+5.66% | 111B | |
+11.23% | 105B | |
-12.15% | 22.34B | |
-2.68% | 21.93B | |
-5.61% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |